The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
Open accessAbstract
BACKGROUND: Recent reports suggest that the rate and severity of Clostridium difficile-associated disease in the United States are increasing and that the increase may be associated with the emergence of a new strain of C. difficile with increased virulence, resistance, or both. METHODS: A total of 187 C. difficile isolates were collected from eight health care facilities in six states (Georgia, Illinois, Maine, New Jersey, Oregon, and Pennsylvania) in which outbreaks of C. difficile-associated disease had occurred between 2000 and 2003. The isolates were characterized by restriction-endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE), and toxinotyping, and the results were compared with those from a database of more than 6000 isolates obtained before 2001. The polymerase chain reaction was used to detect the recently described binary toxin CDT and a deletion in the pathogenicity locus gene, tcdC, that might result in increased production of toxins A and B. RESULTS: Isolates that belonged to one REA group (BI) and had the same PFGE type (NAP1) were identified in specimens collected from patients at all eight facilities and accounted for at least half of the isolates from five facilities. REA group BI, which was first identified in 1984, was uncommon among isolates from the historic database (14 cases). Both historic and current (obtained since 2001) BI/NAP1 isolates were of toxinotype III, were positive for the binary toxin CDT, and contained an 18-bp tcdC deletion. Resistance to gatifloxacin and moxifloxacin was more common in current BI/NAP1 isolates than in non-BI/NAP1 isolates (100 percent vs. 42 percent, P<0.001), whereas the rate of resistance to clindamycin was the same in the two groups (79 percent). All of the current but none of the historic BI/NAP1 isolates were resistant to gatifloxacin and moxifloxacin (P<0.001). CONCLUSIONS: A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geographically dispersed outbreaks of C. difficile-associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Guideline for hand hygiene in health-care settings
Boyce, J. M., & Pittet, D. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.130391 · Cited by 2,120
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Sehulster, L. M., & Chinn, R. Y. W. (2003) · PubMed · Cited by 1,708
Boyce, J. M., & Pittet, D. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/503164 · Cited by 1,655
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Self-citationAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Guideline for Isolation Precautions in Hospitals
Garner, J. S., & Hospital Infection Control Practices Advisory Committee (1996) · Infection Control & Hospital Epidemiology · doi:10.1086/647190 · Cited by 1,068
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Clostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Self-citation
Cited by
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Self-citationMcDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Self-citationBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Self-citationAntibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,020
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome
Sebaihia, M., Wren, B. W., Mullany, P., Fairweather, N. F., Minton, N., Stabler, R., Thomson, N. R., Roberts, A. P., Cerdeño-Tárraga, A. M., Wang, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1830 · Cited by 879
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes
Guh, A. Y., Mu, Y., Winston, L. G., Johnston, H., Olson, D., Farley, M. M., Wilson, L. E., Holzbauer, S. M., Phipps, E. C., Dumyati, G. K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910215 · Cited by 851
Self-citationThe Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Self-citationTreatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Self-citationToxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
Self-citationThe intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D., Bamford, K. B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2478 · Cited by 735
Self-citationClostridium difficile infection: review
Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E. J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03539-6 · Cited by 702
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
“In the early 2000s, clinicians around the world noted an increased severity among patients with CDIs (15, 207).”
BackgroundInfluentialMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W., & Kuijper, E. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592257 · Cited by 637
The epidemiology of community-acquired Clostridium difficile infection: a population-based study
Khanna, S., Pardi, D. S., Aronson, S. L., Kammer, P. P., Orenstein, R., St Sauver, J. L., Harmsen, S. W., & Zinsmeister, A. R. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.398 · Cited by 622
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit278 · Cited by 592
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
O’Grady, N. P., Barie, P. S., Bartlett, J. G., Bleck, T., Carroll, K., Kalil, A. C., Linden, P., Maki, D. G., Nierman, D., Pasculle, W., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318169eda9 · Cited by 600
Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era
Polage, C. R., Gyorke, C. E., Kennedy, M. A., Leslie, J. L., Chin, D. L., Wang, S., Nguyen, H. H., Huang, B., Tang, Y.-W., Lee, L. W., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4114 · Cited by 593
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S., Skaros, S., Weber, L. R., Komorowski, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570
Recommendations for Surveillance of Clostridium difficile–Associated Disease
McDonald, L. C., Coignard, B., Dubberke, E., Song, X., Horan, T., Kutty, P. K., & the Ad Hoc Clostridium difficile Surveillance Working Group (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/511798 · Cited by 558
Self-citationRiggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. P., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 550
Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540
Johnson, S., Louie, T. J., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D., Gelone, S. P., Broom, C., Davidson, D. M., & for the Polymer Alternative for CDI Treatment (PACT) investigators (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu313 · Cited by 527
Self-citationIncidence of Clostridium difficile Infection in Inflammatory Bowel Disease
Rodemann, J. F., Dubberke, E. R., Reske, K. A., Seo, D. H., & Stone, C. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.027 · Cited by 522
MACFABE, D., CAIN, D., RODRIGUEZCAPOTE, K., FRANKLIN, A., HOFFMAN, J., BOON, F., TAYLOR, A., KAVALIERS, M., & OSSENKOPP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.025 · Cited by 497
“Antibiotic resisant clostridial strains play a role in a wide variety of hospital nd community acquired infections [102] in adult patients, but heir role in paediatric diarrhoea related to antibiotic treatment as not been extensively studied [61].”
BackgroundMultilocus Sequence Typing of Clostridium difficile
Griffiths, D., Fawley, W., Kachrimanidou, M., Bowden, R., Crook, D. W., Fung, R., Golubchik, T., Harding, R. M., Jeffery, K. J. M., Jolley, K. A., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01796-09 · Cited by 475
Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile
Britton, R. A., & Young, V. B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.059 · Cited by 446
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
Current Status of Clostridium difficile Infection Epidemiology
Lessa, F. C., Gould, C. V., & McDonald, L. C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis319 · Cited by 439
Self-citationCammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
Carey-Ann, B. D., & Carroll, K. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-13 · Cited by 423
Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
Gerding, D. N., Johnson, S., Rupnik, M., & Aktories, K. (2014) · Gut Microbes · doi:10.4161/gmic.26854 · Cited by 416
Self-citationInfections caused by Gram-positive bacteria: a review of the global challenge
Woodford, N., & Livermore, D. M. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60003-7 · Cited by 410
Nguyen, G. C., Kaplan, G. G., Harris, M. L., & Brant, S. R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01780.x · Cited by 401
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
Garey, K. W., Sethi, S., Yadav, Y., & DuPont, H. L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.08.012 · Cited by 376
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Antibiotic treatment for Clostridium difficile -associated diarrhoea in adults
Nelson, R. L., Suda, K. J., & Evans, C. T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004610.pub5 · Cited by 366
Lamontagne, F., Labb??, A.-C., Haeck, O., Lesur, O., Lalancette, M., Patino, C., Leblanc, M., Laverdi??re, M., & P??pin, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000236628.79550.e5 · Cited by 359
Evolutionary dynamics of Clostridium difficile over short and long time scales
He, M., Sebaihia, M., Lawley, T. D., Stabler, R. A., Dawson, L. F., Martin, M. J., Holt, K. E., Seth-Smith, H. M. B., Quail, M. A., Rance, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914322107 · Cited by 359
Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain
O'Connor, J. R., Johnson, S., & Gerding, D. N. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.073 · Cited by 357
Self-citationClostridium difficile infection: epidemiology, risk factors and management
Ananthakrishnan, A. N. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 352
Miller, B. A., Chen, L. F., Sexton, D. J., & Anderson, D. J. (2011) · Infection Control & Hospital Epidemiology · doi:10.1086/659156 · Cited by 350
Schwan, C., Stecher, B., Tzivelekidis, T., van Ham, M., Rohde, M., Hardt, W.-D., Wehland, J., & Aktories, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000626 · Cited by 337
Killgore, G., Thompson, A., Johnson, S., Brazier, J., Kuijper, E., Pepin, J., Frost, E. H., Savelkoul, P., Nicholson, B., van den Berg, R. J., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-07 · Cited by 337
Self-citationEastwood, K., Else, P., Charlett, A., & Wilcox, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01082-09 · Cited by 330
Kim, J., Smathers, S. A., Prasad, P., Leckerman, K. H., Coffin, S., & Zaoutis, T. (2008) · Pediatrics · doi:10.1542/peds.2008-0469 · Cited by 321
O'Brien, J. A., Lahue, B. J., Caro, J. J., & Davidson, D. M. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/522676 · Cited by 315
Infection control measures to limit the spread of Clostridium difficile
Vonberg, R.-P., Kuijper, E. J., Wilcox, M. H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P. J., Colville, A., Coignard, B., Daha, T., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01992.x · Cited by 314
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
Theriot, C. M., & Young, V. B. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104115 · Cited by 302
Hall, A. J., Curns, A. T., McDonald, L. C., Parashar, U. D., & Lopman, B. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis386 · Cited by 301
Self-citationBarbut, F., Mastrantonio, P., Delmée, M., Brazier, J., Kuijper, E., & Poxton, I. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01824.x · Cited by 297
Marshall, J. C., & Reinhart, K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02afc · Cited by 294
Sethi, A. K., Al-Nassir, W. N., Nerandzic, M. M., Bobulsky, G. S., & Donskey, C. J. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/649016 · Cited by 289
Economic healthcare costs of Clostridium difficile infection: a systematic review
Ghantoji, S. S., Sail, K., Lairson, D. R., DuPont, H. L., & Garey, K. W. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.10.016 · Cited by 288
Treatment of Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521860 · Cited by 287
Self-citationUpdate of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Francis, M. B., Allen, C. A., Shrestha, R., & Sorg, J. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003356 · Cited by 283
Yokoe, D. S., Mermel, L. A., Anderson, D. J., Arias, K. M., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., Fraser, V., Gerding, D. N., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591060 · Cited by 280
Self-citationStructure and mode of action of clostridial glucosylating toxins: the ABCD model
Jank, T., & Aktories, K. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.01.011 · Cited by 279
Thia, K. T., Mahadevan, U., Feagan, B. G., Wong, C., Cockeram, A., Bitton, A., Bernstein, C. N., & Sandborn, W. J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20608 · Cited by 278
Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649213 · Cited by 278
Clostridium diffcile associated infection, diarrhea andcolitis
Hookman, P., & Barkin, J. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1554 · Cited by 275
Clostridium difficile Infection: A Worldwide Disease
Burke, K. E., & Lamont, J. T. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.1.1 · Cited by 274
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Hong, D. J., Bae, I. K., Jang, I.-H., Jeong, S. H., Kang, H.-K., & Lee, K. (2015) · Infection & Chemotherapy · doi:10.3947/ic.2015.47.2.81 · Cited by 271
Merrigan, M., Venugopal, A., Mallozzi, M., Roxas, B., Viswanathan, V. K., Johnson, S., Gerding, D. N., & Vedantam, G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00445-10 · Cited by 271
Self-citationReeves, A. E., Theriot, C. M., Bergin, I. L., Huffnagle, G. B., Schloss, P. D., & Young, V. B. (2011) · Gut Microbes · doi:10.4161/gmic.2.3.16333 · Cited by 270
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Banerjee, R., & Johnson, J. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02824-14 · Cited by 268
Clostridium difficile in Retail Meat Products, USA, 2007
Songer, J. G., Trinh, H. T., Killgore, G. E., Thompson, A. D., McDonald, L. C., & Limbago, B. M. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1505.081071 · Cited by 265
Self-citationCrook, D. W., Walker, A. S., Kean, Y., Weiss, K., Cornely, O. A., Miller, M. A., Esposito, R., Louie, T. J., Stoesser, N. E., Young, B. C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis499 · Cited by 260
Mapping of poverty and likely zoonoses hotspots
Grace, D., Mutua, F. K., Ochungo, P., Kruska, R. L., Jones, K. E., Brierley, L., Lapar, L., Said, M. Y., Herrero, M., Pham-Duc, P., et al. (2012) · CGSPace A Repository of Agricultural Research Outputs (Consultative Group for International Agricultural Research) · doi:10.13140/rg.2.2.10903.48803 · Cited by 258
Ng, J., Hirota, S. A., Gross, O., Li, Y., Ulke–Lemee, A., Potentier, M. S., Schenck, L. P., Vilaysane, A., Seamone, M. E., Feng, H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.005 · Cited by 258
Clostridium difficile and inflammatory bowel disease
Issa, M., Ananthakrishnan, A. N., & Binion, D. G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20500 · Cited by 257
Babcock, G. J., Broering, T. J., Hernandez, H. J., Mandell, R. B., Donahue, K., Boatright, N., Stack, A. M., Lowy, I., Graziano, R., Molrine, D., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00982-06 · Cited by 257
Eckstein, B. C., Adams, D. A., Eckstein, E. C., Rao, A., Sethi, A. K., Yadavalli, G. K., & Donskey, C. J. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-61 · Cited by 254
Dubberke, E. R., Reske, K. A., Yan, Y., Olsen, M. A., McDonald, L. C., & Fraser, V. J. (2007) · Clinical Infectious Diseases · doi:10.1086/523582 · Cited by 254
Self-citationRecent advances in the understanding of antibiotic resistance in Clostridium difficile infection
Spigaglia, P. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115622891 · Cited by 254
Ricciardi, R. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.7.624 · Cited by 253
Thanissery, R., Winston, J. A., & Theriot, C. M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.03.004 · Cited by 242
“The epidemic strains are often associated with increased production of toxins A and B, increased resistance to fluoroquinolone antibiotics, and production of binary toxin [7].”
BackgroundBiology of Clostridium difficile: Implications for Epidemiology and Diagnosis
Karen C., C., & John G., B. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102824 · Cited by 233
Gut Microbiota and Diarrhea: An Updated Review
Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., & Yin, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625210 · Cited by 219
“difficile – associated disease induced a strong inflammatory response (McDonald et al., 2005; Quesada-Gómez et al., 2015).”
BackgroundLewis, B. B., Buffie, C. G., Carter, R. A., Leiner, I., Toussaint, N. C., Miller, L. C., Gobourne, A., Ling, L., & Pamer, E. G. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv256 · Cited by 197
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012) · mBio · doi:10.1128/mbio.00338-12 · Cited by 191
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options
Lo Vecchio, A., & Zacur, G. M. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834bc9a9 · Cited by 183
Metadata
- Authors
- McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-08
- Volume
- 353
- Issue
- 23
- Pages
- 2433-2441
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2101233913
- Cited by
- 2,006
- References
- 30
- FWCI
- 71.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.